Note: Ingredients listed on restricted chemical lists
EC/CAS
59-50-7
Name of the chemical
Chlorocresol
Concentration
N/A
General Information
Revision date
2020-05-06
Product name
ALFAXAN MULTIDOSE Alfaxalone Injection 10 mg/ml
1.2.1 Relevant identified uses
2. As a sole anaesthetic agent for the induction and maintenance of anaesthesia for the performance of examination or surgical procedures in dogs and cats
supplier name
LIMITED
Manufacturer Name
JUROX PTY LIMITED
Icons in SDS
Company Information
company name
JUROX PTY LIMITED
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H319
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
Physical hazards
Flammable Liquid Category 3.
Health hazards
Eye Irritant Category 2A.
Environmental hazards
Not classified as an environmental hazard using GHS criteria
Signal word
WARNING
Hazard statements
H226 Flammable liquid and vapor. H319 Causes serious eye irritation
Prevention
P210 Keep away from heat / sparks / open flames / hot surfaces – No smoking. P233 Keep container tightly closed. P240 Ground/bond container and receiving equipment. P241 Use explosion-proof electrical/ventilating/lighting/intrinsically safe equipment. P242 Use only non-sparking tools. P243 Take precautionary measures against static charge. P264 Wash hands thoroughly after handling P280 Wear protective gloves / protective clothing / eye protection / face protection
Response
P370 + P378 In case of fire: Use water spray / fog for extinction. P303 + P361 + P353 IF ON SKIN (or hair): Remove / Take off immediately all contaminated clothing. Rinse skin with water / shower. P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P337 + P313 If eye irritation persists: Get medical advice/attention
Storage
P403 + P235 Store in a well-ventilated place. Keep cool.
Disposal
P 501 Dispose of contents / container in accordance with local regulations.
2.3 Other hazards
None known. WHICH DO NOT RESULT IN
Additional information
Anesthetic agent: May cause central nervous system and cardiovascular system effects. May cause drowsiness, dizziness, respiratory depression and unconsciousness. * Exempt on labelling as product is not classified as a “hazardous product” under WHMIS 2015 (Cosmetics, devices, drugs or foods as defined in the Food and Drugs Act are excluded products under WHMIS 2015).
